The role of communication in paediatric drug safety

Claire Stebbing1, Ian C K Wong, Rainu Kaushal

  • 1Paediatric Department, Chase Farm Hospital, Enfield, Middlesex, UK. claire1stebbing@gmail.com

Insights

Effective communication is key to preventing medication errors in children. This review highlights patient-doctor, interprofessional, and researcher-professional dialogue as crucial areas for improving paediatric medication safety.

Area of Science:

  • Healthcare
  • Patient Safety
  • Pediatrics

Background:

  • Medication errors pose significant risks to pediatric patients and incur substantial healthcare costs.
  • Communication is identified as a critical factor in the occurrence, management, and prevention of medication errors.

Purpose of the Study:

  • To review strategies for managing pediatric medication errors.
  • To identify practical applications of research findings for operationalizing error prevention.
  • To examine the role of communication in preventing medication errors.

Main Methods:

  • Literature review focusing on communication's role in pediatric medication safety.
  • Analysis of existing data on communication and error prevention.
  • Identification of key communication domains.

Main Results:

  • Communication is pivotal in managing and preventing pediatric medication errors.
  • Three primary domains for preventative communication were identified: patient-doctor, interprofessional, and researcher/professional dialogue.
  • The review aims to bridge research findings with practical applications in pediatric medication safety.

Conclusions:

  • Enhancing communication across patient-doctor, interprofessional, and researcher-professional interactions is essential for improving pediatric medication safety.
  • Implementing evidence-based communication strategies can mitigate medication errors.
  • This review provides a framework for practical application of communication research in pediatric settings.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...